209 results on '"Miyamae, Takeaki"'
Search Results
2. Kcns3 deficiency disrupts Parvalbumin neuron physiology in mouse prefrontal cortex: Implications for the pathophysiology of schizophrenia
3. Presynaptic Effects of N-Methyl-D-Aspartate Receptors Enhance Parvalbumin Cell–Mediated Inhibition of Pyramidal Cells in Mouse Prefrontal Cortex
4. Mechanisms regulating the properties of inhibition-based gamma oscillations in primate prefrontal and parietal cortices.
5. Interactions between Endogenous L-DOPA and GABAA Systems for Cardiovascular Control in the Rat Nucleus Tractus Solitarii
6. Mechanisms regulating the frequency of inhibition-based gamma oscillations in primate prefrontal and parietal cortices
7. Music-experience-related and musical-error-dependent activations in the brain
8. Music-experience-related and musical-error-dependent activations in the brain.
9. Cholinergic modulation of neuronal excitability and recurrent excitation-inhibition in prefrontal cortex circuits: implications for gamma oscillations
10. Is DOPA a neurotransmitter?
11. Postsynaptic diacylglycerol lipase α mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex
12. Kcns3 Deficiency Disrupts Parvalbumin Neuron Physiology in Mouse Prefrontal Cortex: Implications for the pathophysiology of schizophrenia
13. Endogenously released DOPA is a causal factor for glutamate release and resultant delayed neuronal cell death by transient ischemia in rat striata
14. DOPA cyclohexyl ester potently inhibits aglycemia-induced release of glutamate in rat striatal slices
15. Distinct Properties of Layer 3 Pyramidal Neurons from Prefrontal and Parietal Areas of the Monkey Neocortex
16. 20. Intrinsic Properties of Layer 3 Pyramidal Neurons From Monkey Prefrontal and Parietal Cortices
17. DOPA causes glutamate release and delayed neuron death by brain ischemia in rats
18. Involvement of nitric oxide production via kynurenic acid-sensitive glutamate receptors in DOPA-induced depressor responses in the nucleus tractus solitarii of anesthetized rats
19. Tonic function of nicotinic receptors in stress-induced release of l-DOPA from the nucleus accumbens in freely moving rats
20. l-DOPA Cyclohexyl Ester Is a Novel Potent and Relatively Stable Competitive Antagonist Against l-DOPA Among Several l-DOPA Ester Compounds
21. Involvement of rBAT in Na +-dependent and -independent transport of the neurotransmitter candidate L-DOPA in Xenopus laevis oocytes injected with rabbit small intestinal epithelium poly A + RNA
22. Cell Type- and Layer-Specific Muscarinic Potentiation of Excitatory Synaptic Drive onto Parvalbumin Neurons in Mouse Prefrontal Cortex
23. The evidence for tonic GABAergic regulation of basal l-DOPA release via activation of inhibitory GABA A receptors in the nucleus tractus solitarii of anesthetized rats
24. GABA may function tonically via GABA A receptors to inhibit hypotension and bradycardia by l-DOPA microinjected into depressor sites of the nucleus tractus solitarii in anesthetized rats
25. Some interactions of L-DOPA and its related compounds with glutamate receptors
26. Distinct Physiological Maturation of Parvalbumin-Positive Neuron Subtypes in Mouse Prefrontal Cortex
27. Functional properties of GABA synaptic inputs onto GABA neurons in monkey prefrontal cortex
28. Functional Maturation of GABA Synapses During Postnatal Development of the Monkey Dorsolateral Prefrontal Cortex
29. A seven-transmembrane receptor that mediates avoidance response to dihydrocaffeic acid, a water-soluble repellent in Caenorhabditis elegans
30. P–516 - DOPA does not interact with its competitive antagonists on glutamate nor dopamine receptors.
31. P–517 - Foot shock stress-induced release of DOPA from the nucleus accumbens in rats.
32. P–518 - Evidence that DOPA itself induces c-Fos expression in the rat CNS.
33. P–515 - Is L-DOPA an endogenous potentiator for glutamate release and resultant neuronal death by transient ischemia in rats?
34. S18–6 - Endogenously evoked L-DOPA is a causal factor for glutamate release and resultant delayed neuronal cell death by transient ischemia in rats.
35. Protein phosphatases 1 and 2A are both required for long-term depression and associated dephosphorylation of cAMP response element binding protein in hippocampal area CA1 in vivo
36. LTP- and LTD-inducing stimulations cause opposite changes in arc/arg3.1 mRNA level in hippocampal area CA1 in vivo
37. DOPA cyclohexyl ester, a competitive DOPA antagonist, protects glutamate release and resultant delayed neuron death by transient ischemia in hippocampus CA1 of conscious rats
38. Involvement of rBAT in Na+-dependent and -independent transport of the neurotransmitter candidate L-DOPA in Xenopus laevis oocytes injected with rabbit small intestinal epithelium poly A+ RNA
39. A competitive DOPA antagonist, DOPA cyclohexyl ester, inhibits transient aglycemia-induced glutamate release in rat striatal slices
40. Involvement of nitric oxide in DOPA-induced depressor responses in the nucleus tractus solitarii of anesthetized rats
41. The evidence for tonic GABAergic regulation of basal l-DOPA release via activation of inhibitory GABAA receptors in the nucleus tractus solitarii of anesthetized rats
42. GABA may function tonically via GABAA receptors to inhibit hypotension and bradycardia by l-DOPA microinjected into depressor sites of the nucleus tractus solitarii in anesthetized rats
43. DOPA does not interact with its competitive antagonists on glutamate nor dopamine receptors.
44. Evidence that DOPA itself induces c-Fos expression in the rat CNS.
45. Foot shock stress-induced release of DOPA from the nucleus accumbens in rats.
46. Endogenously evoked L-DOPA is a causal factor for glutamate release and resultant delayed neuronal cell death by transient ischemia in rats.
47. A DOPA antagonist, DOPA cyclohexyl ester inhibits transient brain ischemia-induced release of glutamate and delayed neuronal cell death in striatal and hippocampal region of in vivo rats
48. Is L-DOPA an endogenous potentiator for glutamate release and resultant neuronal death by transient ischemia in rats?
49. Is endogenously released DOPA itself an upstream factor for increase in glutamate release and delayed neuronal cell death induced by transient ischemia in rats?
50. DOPA cyclohexyl ester, a novel, potent and stable competitive antagonist for DOPA, inhibits glutamate release and protects delayed neuronal death in striata induced by brain ischemia of conscious rats
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.